These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17630958)

  • 21. Inflammatory caspases and inflammasomes: master switches of inflammation.
    Martinon F; Tschopp J
    Cell Death Differ; 2007 Jan; 14(1):10-22. PubMed ID: 16977329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Roles of NLRP1 in blood diseases].
    Wu JY; Zeng LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1476-9. PubMed ID: 25338611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
    Namazi MR
    Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations in nalp1 mRNA expressions in human vitiligo.
    Deo SS; Bhagat AR; Shah RN
    Indian J Dermatol; 2011 May; 56(3):266-71. PubMed ID: 21772585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatoglyphics in auto-immune dermatoses.
    Singh PK; Pandey SS; Singh G
    Indian J Dermatol; 1987 Jan; 32(1):15-8. PubMed ID: 3453350
    [No Abstract]   [Full Text] [Related]  

  • 27. Primer: inflammasomes and interleukin 1beta in inflammatory disorders.
    Church LD; Cook GP; McDermott MF
    Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients.
    Ezzedine K; Diallo A; Léauté-Labrèze C; Mossalayi D; Gauthier Y; Bouchtnei S; Cario-André M; Seneschal J; Boralevi F; Jouary T; Taieb A
    Br J Dermatol; 2011 Jul; 165(1):44-9. PubMed ID: 21410675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.
    Pauwels NS; Bracke KR; Dupont LL; Van Pottelberge GR; Provoost S; Vanden Berghe T; Vandenabeele P; Lambrecht BN; Joos GF; Brusselle GG
    Eur Respir J; 2011 Nov; 38(5):1019-28. PubMed ID: 21622588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
    Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
    J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitiligo presentation in adults.
    Mason CP; Gawkrodger DJ
    Clin Exp Dermatol; 2005 Jul; 30(4):344-5. PubMed ID: 15953063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different phenotypes of segmental vitiligo based on a clinical observational study.
    van Geel N; De Lille S; Vandenhaute S; Gauthier Y; Mollet I; Brochez L; Lambert J
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):673-8. PubMed ID: 20840343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitiligo and polyglandular autoimmune endocrinopathy.
    Bloch MH; Sowers JR
    Cutis; 1985 Nov; 36(5):417-9, 421. PubMed ID: 4064762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune diseases associated with neurofibromatosis type 1.
    Nanda A
    Pediatr Dermatol; 2008; 25(3):392-3. PubMed ID: 18577055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of the T cell-specific adaptor (TSAd) protein as an autoimmune disease-regulator in mouse and man.
    Marti F; Lapinski PE; King PD
    Immunol Lett; 2005 Mar; 97(2):165-70. PubMed ID: 15752554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases.
    van Geel N; Speeckaert M; Brochez L; Lambert J; Speeckaert R
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):741-6. PubMed ID: 23590677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus.
    Pontillo A; Girardelli M; Kamada AJ; Pancotto JA; Donadi EA; Crovella S; Sandrin-Garcia P
    Autoimmunity; 2012 Jun; 45(4):271-8. PubMed ID: 22235789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitiligo in Zimbabwe.
    Obe WK
    Cent Afr J Med; 1984 Jan; 30(1):259-64. PubMed ID: 6722868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.